Benign prostatic hyperplasia, also called Benign prostatic hypertrophy or Benign prostatic obstruction, is a common condition in men as they get older. The prostate gland is a walnut-shaped gland p...
Merck's Keytruda-Eisai's Lenvima Combo Make the Cut in Renal Cancer Numerous immunotherapy-based combinations are already trying in the old game of gleek to stake up some share in previously untreated, metastatic kidney cancer; however, the market seems to expand as the new entrants continue to make their entry....
Find MoreCaused by bacteria, viruses, and parasites, Sexually transmitted diseases (STDs) are a global health burden and it seems they are likely to maintain their status of being so in coming years also, primarily due to the lack of knowledge, and awareness. Further, diagnostics and screening, poverty, the stigma associate...
Find MoreNestle acquires peanut allergy treatment with USD 2 Billion Aimmune buyout Nestle has announced a definitive agreement to extend its acquisition of Aimmune Therapeutics. Nestle will pay an additional amount of USD 2 Billion to buy the remaining shares of Aimmune. With the acquisition, Nestle will gain Aimmune's ...
Find MoreInterstitial Cystitis market comprises robust pipeline therapies in late and mid-stage development, which are expected to be launched shortly, such as KRP-116D (Kyorin Pharmaceutical), Certolizumab pegol/ Cimzia (UCB Pharma), LP-08 (Lipella Pharmaceuticals), GRT6010 (Grünenthal), ASP6294 (Astellas Pharma), and SI-...
Find MoreThe Acute Kidney Injury Therapies in the pipeline anticipated to launch in the next decade shall spur the AKI Market growth forward. Acute Kidney Injury (AKI) is defined as a sudden advent of kidney failure or damage due to the accumulation of waste products in the bloodstream resulting in the improper fluid ou...
Find MoreAs per DelveInsight, Acute Kidney Injury Market Size in the 7 MM was observed to be USD 4,082.95 Million in 2017, which is expected to increase by 2030 significantly. Acute Kidney Injury (ARI), formerly known as Acute renal failure (ARF) is a sudden failure of kidneys or damages in the kidney resulting in an u...
Find MoreA biotech company Novome Biotechnologies is developing novel live medicines for chronic diseases, has raised USD 33 Million in Series A financing. The financing was led by DCVC Bio with participation from seed investor 5AM Ventures, Alta Partners, Alexandria Venture Investments and Mayo Clinic. The company plan...
Find MoreThe past few decades have seen significant advancements in the medical sector. Technological intervention is one of them. Discovery of the remarkable property of Stem cells to be able to differentiate into different types of cell forms, replicate and express themselves as their parents is one of the milestone-disco...
Find MoreGlobal Healthcare Opportunities (GHO) Capital, a London-based healthcare investment firm, has recently netted USD 1.1 Billion to advance European healthcare. The company plans to use the proceeds to invest in healthcare companies. Closure of the second round capped at USD 1.1 Billion (Euro 975 Million) is the l...
Find MoreMetachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of.....
Find MoreA formal medical disorder affecting approximately 10 percent of the world population is trypanophobi.....
Find MoreSoft Tissue Sarcoma (STS) tumors constitute 1% of all the malignancies. These are rare neoplasms tha.....
Find MoreMajor Depressive Disorder (MDD), also known as clinical depression, is a severe, debilitating and fr.....
Find MoreThough appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting mi.....
Find MoreHospital-acquired bacterial pneumonia (HABP) is the most common type of health-care-associated infec.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.